Lupin Ltd.
Snapshot View

View in App

Prices View details >>

665.40 +10.60 ▲1.6%

30 September 2022, 11:27:59 AM
Volume: 2,550,626

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lupin.com
Market Cap 29,735.72 Cr.
Enterprise Value(EV) 32,481.75 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -47.50 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 261.83 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.50 Calculated using Price: 654.00
Dividend Yield 0.61 Period Ending 2022-03
No. of Shares Subscribed 45.47 Cr. 454,674,567 Shares
FaceValue 2
Company Profile
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. Lupin is recognised as one of the world's largest manufacturers of Tuberculosis drugs. The company have significant market share across multiple therapy areas such as Cardiovascular (prils and statins), Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). To add to this, the company has proud to maintain over the years its global leadership positions in other therapy areas such as Anti-TB and Cephalosporin.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.62%
1 Week
+2.63%
1 Month
-0.55%
3 Month
+8.91%
6 Month
-11.17%
1 Year
-30.08%
2 Year
-33.95%
5 Year
-34.38%
10 Year
+11.65%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.89 31.09 22.80 20.98 1.91 4.55 -2.12 9.46 -11.79
Return on Capital Employed (%) 40.97 40.30 24.38 18.53 3.54 8.45 6.02 9.70 -7.11
Return on Assets (%) 19.70 21.08 12.82 10.57 0.99 2.32 -1.05 5.09 -6.70

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 5,204 6,932 8,874 11,163 13,498 13,577 13,742 12,537 13,803 12,153
Non Curr. Liab. 573 507 426 6,032 6,447 6,876 7,296 3,003 1,136 1,153
Curr. Liab. 3,007 2,630 3,729 5,061 6,121 5,096 6,130 9,225 8,436 8,276
Minority Int. 59 67 24 32 35 40 47 44 55 69
Equity & Liab. 8,843 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651
Non Curr. Assets 3,700 4,035 5,221 12,402 14,147 13,379 13,362 9,396 9,444 9,194
Curr. Assets 5,143 6,100 7,832 9,887 11,953 12,210 13,854 15,413 13,986 12,458
Misc. Exp. not W/O
Total Assets 8,843 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 11,287 12,770 14,139 17,494 15,804 16,751 16,837 15,163 16,405 15,879
Other Income 116 240 185 107 150 333 484 136 214 238
Total Income 11,403 13,010 14,324 17,601 15,955 17,084 17,320 15,299 16,619 16,117
Total Expenditure -8,284 -9,150 -10,454 -13,001 -12,657 -14,082 -14,362 -12,596 -16,190 -16,443
PBIDT 3,119 3,859 3,871 4,600 3,298 3,002 2,958 2,703 429 -326
Interest -27 -10 -59 -153 -204 -302 -363 -141 -143 -152
Depreciation -261 -435 -487 -912 -1,086 -846 -970 -887 -1,659 -1,643
Taxation -962 -970 -1,059 -979 -288 -902 -1,147 -449 -137 -24
Exceptional Items -1,464 -340 -752
PAT 1,870 2,444 2,265 2,556 255 612 -274 1,227 -1,510 -2,145
Minority Interest -33 -41 -9 -7 -7 -11 -19 -15
Share Associate 5 8 4 -5 4 1 0 0
Other Related Items
Consolidated Net Profit 1,836 2,403 2,261 2,557 251 607 -269 1,217 -1,528 -2,160
Adjusted EPS 41 53 50 57 6 13 -6 27 -34 -48

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,251 2,004 2,733 -382 4,114 1,751 1,666 1,469 1,822 367
Cash Fr. Inv. -522 -859 -1,055 -6,962 -2,527 470 -3,282 1,107 -1,240 1,292
Cash Fr. Finan. -663 -857 -197 5,836 433 -1,492 744 -891 -1,885 -1,572
Net Change 66 288 1,482 -1,508 2,019 729 -872 1,685 -1,303 87
Cash & Cash Eqvt 311 607 2,108 780 2,799 1,416 544 2,229 926 1,013

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 46.92 46.91 46.88 46.86 46.84 46.83 46.81 46.78 47.10
Public 53.08 53.09 53.12 53.14 53.16 53.17 53.19 53.22 52.90
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 29 Sep 2022
General updates
Lupin Limited has informed the Exchange about communication from U.S. FDA regarding the Company???s Tarapur, Maharashtra (India) facility.
Thu, 29 Sep 2022
Press Release
Lupin Limited has informed the Exchange about press release dated 29-Sep-2022 titled Lupin Receives Approval from U.S. FDA for Mirabegron Extended-Release Tablets.
Thu, 29 Sep 2022
Press Release
Lupin Limited has informed the Exchange about press release dated 29-Sep-2022 titled Lupin Receives Approval from U.S. FDA for Mirabegron Extended-Release Tablets.

Technical Scans View Details >>

Thu, 29 Sep 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Making Higher Highs for 3 days Making Higher Highs for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 933.35 +0.3%
Divi's Laboratories Ltd. 97,819.86 3,680.80 -0.4%
Cipla Ltd. 90,339.79 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. 52,359.20 1,548.40 +0.2%
Abbott India Ltd. 40,610.60 19,217.15 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-06 36.30 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-06 50.22 19,217.15 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-06 4.20 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-06 13.62 19,217.15 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-03 0.00 19,217.15 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,217.15 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,217.15 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,217.15 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 933.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,680.80 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.85 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,300.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,391.50 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,548.40 +0.2%
Abbott India Ltd. Standalone 2022-03 798.70 19,217.15 +0.2%

FAQ's On Lupin Ltd.

What is Lupin share price?
Can I buy Lupin shares now?
What is the Dividend Yield of Lupin?
What is the Market Cap of Lupin?
What are the key metrics to analyse Lupin?
What is the 52 Week High and Low of Lupin?
What is the trend of Lupin share price?